We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report Central Asia - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Central Asia - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Central Asia: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Imports

Imports in Central Asia

In 2021, overseas purchases of medicaments containing insulin but not antibiotics increased by 178% to X kg, rising for the second year in a row after two years of decline. In general, imports saw a significant expansion. The most prominent rate of growth was recorded in 2016 when imports increased by 867%. The volume of import peaked in 2021 and is expected to retain growth in the near future.

In value terms, medicaments containing insulin imports skyrocketed to $X in 2021. Overall, imports recorded a significant increase. The most prominent rate of growth was recorded in 2016 when imports increased by 3,411%. The level of import peaked in 2021 and is expected to retain growth in years to come.

Imports by Country

Turkmenistan prevails in imports structure, amounting to X kg, which was near 93% of total imports in 2021. The following importers - Kazakhstan (X kg) and Tajikistan (X kg) - together made up 6.9% of total imports.

Turkmenistan was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of +317.9% from 2012 to 2021. Tajikistan (-4.5%) and Kazakhstan (-6.6%) illustrated a downward trend over the same period. While the share of Turkmenistan (+93 p.p.) and Tajikistan (+2.9 p.p.) increased significantly in terms of the total imports from 2012-2021, the share of Kazakhstan (-96 p.p.) displayed negative dynamics.

In value terms, Turkmenistan ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Central Asia, comprising 96% of total imports. The second position in the ranking was taken by Kazakhstan ($X), with a 2.1% share of total imports.

From 2012 to 2021, the average annual growth rate of value in Turkmenistan totaled +272.4%. In the other countries, the average annual rates were as follows: Kazakhstan (-4.5% per year) and Tajikistan (+3.0% per year).

Import Prices by Country

In 2021, the import price in Central Asia amounted to $X per ton, with an increase of 4.4% against the previous year. In general, the import price continues to indicate a buoyant increase. The pace of growth was the most pronounced in 2016 when the import price increased by 263%. The level of import peaked at $X per ton in 2017; however, from 2018 to 2021, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2021, amid the top importers, the country with the highest price was Turkmenistan ($X per ton), while Kazakhstan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Tajikistan (+7.8%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

Turkmenistan constituted the country with the largest volume of medicaments containing insulin consumption, accounting for 74% of total volume. Moreover, medicaments containing insulin consumption in Turkmenistan exceeded the figures recorded by the second-largest consumer, Tajikistan, threefold.
In value terms, Turkmenistan constitutes the largest market for imported medicaments containing insulin but not antibiotics in Central Asia, comprising 75% of total imports. The second position in the ranking was occupied by Kazakhstan, with a 16% share of total imports.
The medicaments containing insulin import price in Central Asia stood at $165,868 per ton in 2020, jumping by 9,997% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Central Asia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Production in Central Asia, split by region and country
  • Trade (exports and imports) in Central Asia
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY

  8. 8. IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • Kazakhstan
    • Kyrgyzstan
    • Mongolia
    • Tajikistan
    • Turkmenistan
    • Uzbekistan

  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Asia - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 354

This report provides an in-depth analysis of the medicaments containing insulin market in Asia.

World - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 356

This report provides an in-depth analysis of the global medicaments containing insulin market.

EU - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 238

This report provides an in-depth analysis of the medicaments containing insulin market in the EU.

U.S. - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 297

This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..

China - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 248

This report provides an in-depth analysis of the medicaments containing insulin market in China.

Free Data: Medicaments Containing Insulin But Not Antibiotics - Central Asia
Table
Medicaments Containing Insulin But Not Antibiotics - Central Asia - Table
Dashboard
Medicaments Containing Insulin But Not Antibiotics - Central Asia - Dashboard
Report
Medicaments Containing Insulin But Not Antibiotics - Central Asia - Report